A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Clinical trial NCT06089616 · RECRUITING
Trial details
- NCT number
- NCT06089616
- Sponsor
- Ipsen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-05
- Primary completion
- 2035-12-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.